At the 3rd UAREP-sponsored Molecular Diagnostics Workshop held in Bethesda, Maryland in November 1994, Association for Molecular Pathology (AMP) was founded. An Action Committee was set up to formally establish the Association and create a framework for the future growth and development of AMP.

Dr. David L. Cooper, PhD, MD, who had established the first Division of Molecular Pathology ever in the field at University of Pittsburgh Medical Center (UPMC) and had served as the Founding Editor for the Journal of Molecular Diagnosis and Therapy (Springer), was elected as the Chair of the Action Committee and the First President of AMP. 

At that time, none of the large pathology societies had much interest in promoting molecular pathology, so the members of the action committee decided that a free-standing society was preferable to affiliation with an established group. Although the members were all Americans then, they chose the name Association for Molecular Pathology so that it specifically did not contain the words “national” or “American” and would thus represent an international effort, and an organization without borders.

The first Annual Meeting was held at Hyatt Regency, Minneapolis, MN on November 10 – 12, 1995

Meeting Highlights:

• Society Bylaws adopted November 12, 1995.
• “Youthquake” for those who were there.
• Social event at Speakeasy Cave in St. Paul where “Guido” (aka David Cooper) was the star.

Society Highlights:

• The association’s Listserv bit.listserv.mxdiag-l facilitated internet communication prior to CHAMP.
• Ron McGlennen, Editor of the first AMP Newsletter.
• Fran Pitlick, Executive Officer of UAREP and ASIP, AMP’s first Executive Officer. 

In 2019, to celebrate AMP’s 25th anniversary, the members compiled a timeline of notable events and initiatives that made AMP the vibrant society.

ABOUT AMP

The Association for Molecular Pathology (AMP) was founded in 1995 to provide structure and leadership to the emerging field of molecular diagnostics. AMP’s 2,600+ members include individuals from academic and community medical centers, government, and industry; including pathologist and doctoral scientist laboratory directors; basic and translational scientists; technologists; and trainees.

Through the efforts of its Board of Directors, Committees, Working Groups, and members, AMP is the primary resource for expertise, education, and collaboration in one of the fastest growing fields in healthcare. AMP members influence policy and regulation on the national and international levels, ultimately serving to advance innovation in the field and protect patient access to high quality, appropriate testing.

AMP is a nonprofit corporation, incorporated in the State of Maryland, and tax exempt under IRC 501(c)3.

MISSION

The Association for Molecular Pathology is a not-for-profit scientific society that advances the clinical practice, science, and excellence of molecular and genomic laboratory medicine through education, innovation, and advocacy to enable highest quality health care.

VISION

The Association for Molecular Pathology provides global expertise in molecular testing that drives patient care.

About PhytoDental Solutions

PhytoDental Solutions (“PDS”) is dedicated to developing phytocannabinoid-based and augmented formulations for applications across the spectrum of dental diseases and surgical procedures, to provide patients with products of special effect for daily oral care, and at the same time, introducing advanced technology to build a system of precision dentistry to systematically solve the long-standing pain points in the dental and health management industries.

PDS provides a series of professional and consumer products including clinically and statistically validated indication specific formulation products for dental anxiety, denture stomatitis, orthodontic caries and gingivitis, periodontitis, peri-implantitis, pre-, post- dental surgical care, and anti-inflammatory consumer products including toothpaste, dental floss, mouthwash and a series of dental appliances for home use.

PDS indication special formulations are capable of forming a powerful supplement or even replacement for the obvious clinical defects of most products in the dental market.

By promoting the precise application of cannabinoids in dentistry to block the common “oral entrance of pathogens”, the systemic health of patients is improved, and an innovative new model of health management – “Dental Health is Well Health” created.